20.53 USD
+0.27 (+1.33%)
We assign a fundamental rating of 6 out of 10 to SLP. SLP was compared to 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
- In the past year SLP was profitable.
- In the past year SLP had a positive cash flow from operations.
- Of the past 5 years SLP 4 years were profitable.
- In the past 5 years SLP always reported a positive cash flow from operatings.
1.2 Ratios
- SLP's Return On Assets of -46.61% is on the low side compared to the rest of the industry. SLP is outperformed by 68.57% of its industry peers.
- SLP's Return On Equity of -50.54% is in line compared to the rest of the industry. SLP outperforms 48.57% of its industry peers.
- SLP has a Return On Invested Capital of 4.45%. This is in the better half of the industry: SLP outperforms 74.29% of its industry peers.
- SLP had an Average Return On Invested Capital over the past 3 years of 3.61%. This is below the industry average of 6.63%.
- The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROIC | 4.45% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
- Looking at the Operating Margin, with a value of 9.00%, SLP belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
- SLP's Operating Margin has declined in the last couple of years.
- The Gross Margin of SLP (59.60%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of SLP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
- SLP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, SLP has more shares outstanding
- Compared to 5 years ago, SLP has more shares outstanding
- There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 23.66 indicates that SLP is not in any danger for bankruptcy at the moment.
- SLP has a Altman-Z score of 23.66. This is amongst the best in the industry. SLP outperforms 97.14% of its industry peers.
- There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 23.66 |
ROIC/WACC0.46
WACC9.7%
2.3 Liquidity
- SLP has a Current Ratio of 5.62. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 5.62, SLP belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
- A Quick Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 5.62, SLP belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 50.00% over the past year.
- Measured over the past 5 years, SLP shows a small growth in Earnings Per Share. The EPS has been growing by 1.07% on average per year.
- SLP shows a small growth in Revenue. In the last year, the Revenue has grown by 5.69%.
- The Revenue has been growing by 13.74% on average over the past years. This is quite good.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
- Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 22.12% on average per year.
- SLP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.39% yearly.
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 34.22 indicates a quite expensive valuation of SLP.
- 71.43% of the companies in the same industry are more expensive than SLP, based on the Price/Earnings ratio.
- SLP's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.94.
- The Price/Forward Earnings ratio is 21.10, which indicates a rather expensive current valuation of SLP.
- Based on the Price/Forward Earnings ratio, SLP is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 23.94. SLP is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.22 | ||
| Fwd PE | 21.1 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than 62.86% of the companies in the same industry.
- 77.14% of the companies in the same industry are more expensive than SLP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.75 | ||
| EV/EBITDA | 25.53 |
4.3 Compensation for Growth
- SLP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.06
PEG (5Y)32.04
EPS Next 2Y29.52%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
- SLP has a yearly dividend return of 0.61%, which is pretty low.
- SLP's Dividend Yield is rather good when compared to the industry average which is at 0.54. SLP pays more dividend than 94.29% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.83, SLP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
NASDAQ:SLP (1/21/2026, 11:58:43 AM)
20.53
+0.27 (+1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-01 2026-04-01
Inst Owners79.38%
Inst Owner Change0.02%
Ins Owners17.2%
Ins Owner Change-0.18%
Market Cap413.47M
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Analysts80
Price Target24.23 (18.02%)
Short Float %7.04%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.28%
Min EPS beat(2)-77.15%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)71.31%
Min EPS beat(4)-77.15%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)23.48%
EPS beat(12)5
Avg EPS beat(12)8.75%
EPS beat(16)7
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.77%
Max Revenue beat(2)1.36%
Revenue beat(4)4
Avg Revenue beat(4)1.01%
Min Revenue beat(4)0.63%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.57%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)0.08%
PT rev (1m)3.26%
PT rev (3m)-6.25%
EPS NQ rev (1m)-17.01%
EPS NQ rev (3m)37.85%
EPS NY rev (1m)88.82%
EPS NY rev (3m)82.04%
Revenue NQ rev (1m)1.69%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0.6%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.22 | ||
| Fwd PE | 21.1 | ||
| P/S | 5.26 | ||
| P/FCF | 20.75 | ||
| P/OCF | 17.49 | ||
| P/B | 3.25 | ||
| P/tB | 7.57 | ||
| EV/EBITDA | 25.53 |
EPS(TTM)0.6
EY2.92%
EPS(NY)0.97
Fwd EY4.74%
FCF(TTM)0.99
FCFY4.82%
OCF(TTM)1.17
OCFY5.72%
SpS3.91
BVpS6.31
TBVpS2.71
PEG (NY)1.06
PEG (5Y)32.04
Graham Number9.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROCE | 5.55% | ||
| ROIC | 4.45% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 29.44% | ||
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% | ||
| FCFM | 25.32% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 50.91% | ||
| Cap/Sales | 4.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 164.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 | ||
| Altman-Z | 23.66 |
F-Score6
WACC9.7%
ROIC/WACC0.46
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y33.64%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.92%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y53.44%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.52%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to grow by 32.34% in the next year.